A study published in the BMJ has advised against the use of apps to assess the risk of skin cancer.
Primarily targeted at catching early-stage melanoma by photographing suspicious skin lesions on a smartphone, the apps were found to be subject to “poor and variable performance”, in spite of one having gained CE marking.
The discrepancy has led the authors to condemn the European regulatory...
